MedPath

Effectiveness of abdominal compression maneuver on neck vein distention and its influence on intra-abdominal pressure and on cardiac functioning of mechanically ventilated childre

Not Applicable
Conditions
Intra-Abdominal Hypertension
Cardiac Output, Low
Child, Hospitalized
Critical Care
C05.651.180.297
C14.280.148
M01.643.259
E02.760.190
Registration Number
RBR-3mr2vm
Lead Sponsor
Hospital das Clínicas da Universidade Estadual de Campinas
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Age between 28 days and 14 years old; need for central venous catheterization due to the clinical condition that justified the hospitalization; presence of bladder catheter that allows IAP measurement; patients with clinical criteria for IAP monitoring due to the risk of abdominal hypertension caused by the disease that justified their hospitalization; patients under invasive mechanical ventilation with tidal volume between 8 and 10 ml / kg of ideal weight and mean airway pressure between 8 and 12 cmH20; hemodinamically stable patients defined as age-appropriate heart rate and blood pressure (between the 10th and 90th percentiles); patients with respiratory stability defined as age-appropriate respiratory rate and arterial O2 saturation greater than 94% as measured by pulse oximetry; availability of the researcher responsible for performing the ultrasound exam.

Exclusion Criteria

Previous venous thrombosis in internal jugular veins; presence of collateral venous circulation in the cervical region in patients with a history of previous internal jugular vein catheterizations; Initial intra-abdominal pressure greater than 12 mmHg; peritoneal dialysis; skin lesions in the right upper quadrant of the abdomen; skin lesions in the cervical region; continuous dobutamine infusion at doses greater than 5 mcg / kg / min, adrenaline at doses greater than 0.1 mcg / kg / min, noradrenaline at doses greater than 0.1 mcg / kg / min, or milrinone at doses greater than 0.25 mcg / kg / min; intense psychomotor agitation impairing ultrasound examination.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath